From epidemiology and neurodevelopment to antineoplasticity. Medroxyprogesterone reduces human glial tumor growth in vitro and C6 glioma in rat brain in vivo

Sadeleştirilmiş öğe sayfası
dc.contributor.authorAltinoz, Meric A.
dc.contributor.authorNalbantoglu, Josephine
dc.contributor.authorOzpinar, Aysel
dc.contributor.authorOzcan, M. Emin
dc.contributor.authorDel Maestro, Rolando F.
dc.contributor.authorElmaci, Ilhan
dc.date.accessioned2025-10-16T15:24:58Z
dc.date.issued2018
dc.identifier.doi10.1016/j.clineuro.2018.07.012
dc.identifier.otherWOS:000446287500004
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/8184
dc.publisherELSEVIER SCIENCE BV
dc.sourceCLINICAL NEUROLOGY AND NEUROSURGERY
dc.subjectMedroxyprogesterone
dc.subjectProgesterone analogues
dc.subjectDexamethasone
dc.subjectTemozolomide
dc.subjectGlioblastoma
dc.titleFrom epidemiology and neurodevelopment to antineoplasticity. Medroxyprogesterone reduces human glial tumor growth in vitro and C6 glioma in rat brain in vivo
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS